文献速递免疫规划

壳聚糖/海藻酸盐微颗粒用于口服禽伤寒疫苗:先天性与获得性免疫

Chitosan/alginate microparticles for the oral delivery of fowl typhoid vaccine: Innate and acquired immunity.
PubMed 文献 · Vaccine · 2018-07-13

本研究将60只一日龄雏鸡分为三组,分别给予阴性对照、皮下注射9R活疫苗及壳聚糖/海藻酸盐微颗粒包衣的口服9R活疫苗,于10周和14周龄接种、16周龄攻毒。结果显示口服包衣疫苗与皮下接种在免疫应答上无显著差异(p < 0.05),攻毒后两组保护率均为100%且无死亡。

要点

  • 微颗粒粒径0.55 µm至10 µm,包封率高于60%。
  • 首免后OCV 567组ELISA E值0.10 ± 0.14,SC 634组0.07 ± 0.01,NEG 451组0.02 ± 0.01。
  • 攻毒后OCV 567与SC 634组均100%保护且无死亡。

核心结论

  • 口服壳聚糖/海藻酸盐微颗粒包衣禽伤寒疫苗与皮下接种途径在免疫应答上无显著差异(p < 0.05)。
  • 口服途径的保护效力归因于壳聚糖/海藻酸盐生物聚合物包衣防止疫苗在胃肠道中被破坏。

研究设计与样本

  • 研究将60只一日龄雏鸡分为三组,每组20只:阴性对照组NEG 451(未接种未攻毒,用于细胞因子定量对照)、SC 634组(注射途径9R活疫苗)和OCV 567组(壳聚糖/海藻酸盐微颗粒包衣的9R活疫苗)。
  • 于10周龄和14周龄接种,16周龄攻毒;用ELISA检测IgG,用qRT-PCR计算脾脏IFN-γ mRNA倍数表达。
  • 初步研究评估了粒径、包封效率和凝集反应。

主要发现

  • 粒径范围为0.55 µm至10 µm,包封率高于60%。
  • 首免后ELISA E值:OCV 567组0.10 ± 0.14,SC 634组0.07 ± 0.01,NEG 451组0.02 ± 0.01。
  • 加强免疫后ELISA E值:SC 634组0.25 ± 0.16,OCV 567组0.19 ± 0.04,NEG 451组0.0008 ± 0.005。
  • 脾脏IFN-γ表达(2-ΔΔ CT法)上调:OCV 567组为1.97,SC 634组为0.75。
  • 用85-kb毒力质粒SG9攻毒后,OCV 567和SC 634组均100%保护且无死亡。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Oral fowl typhoid (FT) vaccine is necessary for improved flock vaccinations and economic growth. This study was undertaken to evaluate the immune responses of birds given oral fowl typhoid vaccine coated with chitosan/alginate microparticles and comparing it with the conventional subcutaneous route of administration. Preliminary studies were done to evaluate the particle size, encapsulation efficiency and agglutination. Sixty day-old chicks were divided into three groups of twenty birds each. This comprised a negative control group NEG 451 (non-vaccinated and non-challenged used as control for cytokine quantification), SC 634 (live 9R vaccine by the injection route) and OCV 567 (live 9R vaccine coated with chitosan/alginate microparticles). Vaccination was done at 10 weeks and 14 weeks of age followed by challenge at 16 weeks of age. IgG was measured using ELISA. mRNA fold expression of IFN-γ in spleen was calculated using qRT-PCR. Particle sizes ranged between 0.55 µm and 10 µm. Encapsulation efficiency was above 60%. ELISA showed E-values of 0.10 ± 0.14, 0.07 ± 0.01 and 0.02 ± 0.01 for OCV 567, SC 634 and NEG 451 respectively after primary vaccination. Also E-values were 0.25 ± 0.16, 0.19 ± 0.04 and 0.0008 ± 0.005 for SC 634, OCV 567 and NEG451 respectively after boost vaccination. The expression of IFN-γin spleen using 2-ΔΔ CT calculation was upregulated with values of 1.97 and 0.75 for OCV 567 and SC 634 respectively. After challenge with the 85-kb virulence plasmid SG9, there was 100% protection of the birds in both OCV 567 and SC 634 groups with no mortality. In conclusion, there was no significant difference at p < 0.05 of the means ± SD in immune responses between the oral fowl typhoid vaccine coated with chitosan/alginate microparticles and the subcutaneous route of administration. However, it is noteworthy to mention that the protective efficacy of the oral route is due to the chitosan/alginate biopolymers which coated the vaccine preventing destruction in the gastrointestinal tract.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Onuigbo E, Iseghohimhen J, Chah K, et al. Chitosan/alginate microparticles for the oral delivery of fowl typhoid vaccine: Innate and acquired immunity. Vaccine. 2018. PMID: 30017142. doi:10.1016/j.vaccine.2018.05.087

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。